What is the price target for AXGN stock?
16 analysts have analysed AXGN and the average price target is 41.62 USD. This implies a price increase of 20.77% is expected in the next year compared to the current price of 34.46.
AXOGEN INC (AXGN) Forecast, Price Target & Analyst Ratings
NASDAQ:AXGN • US05463X1063
Current stock price
34.46 USD
+0.99 (+2.96%)
At close:
34.5174 USD
+0.06 (+0.17%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AXOGEN INC (AXGN).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.10
- Revenue Estimate
- 58.903M
Price Target Details & History
Consensus Price Target and Range
Mean target
$41.62
Upside
+ 20.77%
From current price of $34.46 to mean target of $41.62, Based on 16 analyst forecasts
Low
$39.39
Median
$40.80
High
$45.15
Price Target Revisions
1 Month
9.20%
3 Months
12.09%
Price Target Summary
16 Wall Street analysts provided a forecast for the next 12 months for AXGN. The average price target is 41.62 USD. This implies a price increase of 20.77% is expected in the next year compared to the current price of 34.46.
The average price target has been revised upward by 12.09% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
83.75%
AXGN was analyzed by 16 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about AXGN.
In the previous month the buy percentage consensus was at a similar level.
AXGN was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-02-24 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2026-02-19 | Wells Fargo | Initiate | Overweight |
| 2025-12-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-12-04 | Lake Street | Maintains | Buy -> Buy |
| 2025-12-04 | Jefferies | Maintains | Buy -> Buy |
| 2025-12-01 | Mizuho | Initiate | Outperform |
| 2025-10-30 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-10-30 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-10-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-30 | HC Wainwright & Co. | Initiate | Buy |
| 2025-05-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-17 | Lake Street | Initiate | Buy |
| 2025-03-05 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-26 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-02-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-03 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-07-01 | Raymond James | Initiate | Outperform |
| 2024-06-20 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2024-01-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-12-07 | Canaccord Genuity | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.10
- Revenue Estimate
- 58.903M
- Revenue Q2Q
- 21.30%
- EPS Q2Q
- 590.31%
- Number of Analysts
- 11
Next Earnings Revisions
Revenue (1 Month)
0.07%
Revenue (3 Months)
0.88%
EPS (1 Month)
19.43%
EPS (3 Months)
41.38%
Next Earnings Summary
AXGN is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.1 USD and the consensus revenue estimate is 58.90M USD.
The next earnings revenue estimate has been revised upward by 0.88% in the past 3 months.
Full Analyst Estimates 2026 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 159.012M 14.73% | 187.338M 17.81% | 225.208M 20.21% | 271.59M 20.60% | 316.28M 16.45% | 370.87M 17.26% | 431.41M 16.32% | 542.54M 25.76% | 588.54M 8.48% | 679.32M 15.42% | |
| EBITDA YoY % growth | -16.971M 36.20% | 3.447M 120.31% | -874K -125.36% | 39.464M 4,615.33% | 54.325M 37.66% | 75.276M 38.57% | 94.554M 25.61% | 121.07M 28.04% | N/A | N/A | |
| EBIT YoY % growth | -21.462M 27.74% | -3.287M 84.68% | -7.849M -138.79% | 4.258M 154.25% | 20.48M 380.98% | 43.35M 111.67% | 53.754M 24.00% | 76.194M 41.75% | 93.84M 23.16% | 119.34M 27.17% | |
| Operating Margin | -13.50% | -1.75% | -3.49% | 1.57% | 6.48% | 11.69% | 12.46% | 14.04% | 15.94% | 17.57% | |
| EPS YoY % growth | -0.18 40.00% | 0.13 172.22% | 0.29 123.08% | 0.56 91.69% | 0.83 50.09% | 1.10 31.30% | 1.34 22.44% | 1.73 29.28% | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.10 590.31% | 0.16 34.42% | 0.18 46.93% | 0.18 158.12% | 0.17 69.02% | 0.19 15.40% | 0.20 15.70% | 0.22 22.78% |
| Revenue Q2Q % growth | 58.903M 21.30% | 67.94M 19.90% | 71.855M 19.59% | 72.473M 20.98% | 68.884M 16.94% | 78.574M 15.65% | 82.178M 14.37% | 83.912M 15.78% |
| EBITDA Q2Q % growth | 5.978M 4,361.19% | 10.459M 101.52% | 11.33M 58.24% | 11.621M 515.48% | 9.486M 58.68% | 9.792M -6.38% | 11.424M 0.83% | 14.178M 22.00% |
| EBIT Q2Q % growth | -2.096M -26.21% | 1.387M -17.05% | 3.25M 69.98% | 2.903M 129.71% | 1.734M 182.71% | 2.754M 98.56% | 4.08M 25.54% | 5.61M 93.25% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
55.74%
EPS Next 5 Year
43.00%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
17.47%
Revenue Next 5 Year
18.85%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
185.35%
EBIT Next 5 Year
106.30%
AXOGEN INC / AXGN Forecast FAQ
What is the next earnings date for AXGN stock?
AXOGEN INC (AXGN) will report earnings on 2026-05-06.
Can you provide the consensus estimates for AXOGEN INC next earnings?
The consensus EPS estimate for the next earnings of AXOGEN INC (AXGN) is 0.1 USD and the consensus revenue estimate is 58.90M USD.
What is the expected long term growth rate for AXOGEN INC (AXGN)?
The expected long term growth rate for AXOGEN INC (AXGN) is 17.47%.